Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
biotech stock review

Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.

Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to...
video

StHealth Private Equity Medtech Fund. Alternative Investment BDC.

StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with...
Hapbee

Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.

Originally posted on MartechSeries. The innovative augmentative wearable device, Hapbee, has been giving testers a reason to be happy....

GeoVax Live Webcast

Tonight, Monday at 5:30 PM. And You Don't Fly to Newport Beach and Deal With all the Drinking, Investment Bankers, and...
roland rick perry

Can This Diabetes Drug Make you Smarter?

OKAY, maybe not make you smarter, but a new study out today says it may delay the onset of dementia - so...
Hapbee, Biotech Stock Review

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...
Biotech Stock Review

Meet The Billion-Dollar Family Company That Makes Purell (Forbes).

Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946. Forbes 3/20/2020 Panic buying is...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!